CO4370014A1 - Soluciones inyectables estables de diritromicina - Google Patents

Soluciones inyectables estables de diritromicina

Info

Publication number
CO4370014A1
CO4370014A1 CO95011794A CO95011794A CO4370014A1 CO 4370014 A1 CO4370014 A1 CO 4370014A1 CO 95011794 A CO95011794 A CO 95011794A CO 95011794 A CO95011794 A CO 95011794A CO 4370014 A1 CO4370014 A1 CO 4370014A1
Authority
CO
Colombia
Prior art keywords
lipophyl
directromycin
stable
injectable solutions
injectable solution
Prior art date
Application number
CO95011794A
Other languages
English (en)
Inventor
Stefan Leiner
Bernhard Hassel
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of CO4370014A1 publication Critical patent/CO4370014A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. SOLUCION INYECTABLE QUE CONTIENE DIRITROMICINA COMO SUSTANCIA ACTIVA EN UNA MEZCLA DE DISOLVENTES FARMACOLOGICAMENTE COMPATIBLE, UNIFASICA, QUE CONTIENE AGUA Y LIPOFILA. 2. SOLUCION INYECTABLE SEGUN LA REIVINDICACION 1, CARACTERIZADA PORQUE LA MEZCLA DE DISOLVENTES LIPOFILA CONSTA DE UN COMPONENTE LIPOFILO Y UN DISOLVENTE ORGANICO ANFIFILO O HIDROFILO. 6. SOLUCION INYECTABLE SEGUN UNA DE LAS PRECEDEN- TES REIVINDICACIONES, CARACTERIZADA PORQUE CONTIE- NE MIRISTATO DE ISOPROPILO COMO COMPONENTE LIPO- FILO Y ETANOL COMO DISOLVENTE HIDROFILO.
CO95011794A 1994-03-26 1995-03-23 Soluciones inyectables estables de diritromicina CO4370014A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4410637A DE4410637C1 (de) 1994-03-26 1994-03-26 Injizierbare Lösungen von Dirithromycin

Publications (1)

Publication Number Publication Date
CO4370014A1 true CO4370014A1 (es) 1996-10-07

Family

ID=6514000

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95011794A CO4370014A1 (es) 1994-03-26 1995-03-23 Soluciones inyectables estables de diritromicina

Country Status (7)

Country Link
EP (1) EP0754047A1 (es)
JP (1) JPH09510722A (es)
AU (1) AU2214195A (es)
CO (1) CO4370014A1 (es)
DE (1) DE4410637C1 (es)
WO (1) WO1995026191A1 (es)
ZA (1) ZA952405B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518917A1 (de) * 1995-05-23 1996-11-28 Boehringer Ingelheim Vetmed Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
US4918108A (en) * 1982-03-16 1990-04-17 Boehringer Ingelheim Vetmedica Gmbh Method of improving the absorption of injected antibacterial substances
DE3209429A1 (de) * 1982-03-16 1983-10-06 Boehringer Ingelheim Vetmed Mittel zur verbesserung der resorption von injizierten antibakteriell wirksamen substanzen und kombinationen, enthaltend ein benzyaminderivat
AU630469B2 (en) * 1989-05-26 1992-10-29 Abbott Laboratories Injectable clarithromycin composition

Also Published As

Publication number Publication date
JPH09510722A (ja) 1997-10-28
EP0754047A1 (de) 1997-01-22
DE4410637C1 (de) 1995-09-21
WO1995026191A1 (de) 1995-10-05
ZA952405B (en) 1995-09-26
AU2214195A (en) 1995-10-17

Similar Documents

Publication Publication Date Title
ES2174968T3 (es) Preparacion de microcapsulas huecas.
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
ATE168556T1 (de) Stabile budesonid-lösungen, verfahren zu deren herstellung sowie verwendung dieser lösungen als klistierzubereitungen und pharmazeutische schäume
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
NO20001567D0 (no) Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler
ATE63220T1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
FI875272A (fi) Baerarloesningsmedelssystem i tvao fas.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
PT916347E (pt) Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas
ATE15596T1 (de) Pharmazeutische mittel.
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
AR012217A1 (es) Una composicion topica para mejorar la penetracion de compuestos farmaceuticos
IT8821271A0 (it) Derivati benzimidazolici farmacologicamente attivi.
NO20020835D0 (no) Blandinger for inhalering omfattende delta-9- tetrahydrokannabinol i et semivandig lösningsmiddel
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
YU12397A (en) NOVEL PYRIMIDO [1,2-a] INDOLES
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ES2193007T1 (es) Formulacion farmaceutica estable que comprende la modificacion ii de torsemida.